This work aimed to evaluate the potential role of the 5-HT(7) receptor in nociception secondary to a sensitizing stimulus in mice. For this purpose, the effects of relevant
ligands (5-HT(7) receptor agonists: AS-19, MSD-5a, E-55888; 5-HT(7) receptor antagonists:
SB-258719,
SB-269970; 5-HT(1A) receptor agonist:
F-13640; 5-HT(1A) receptor antagonist:
WAY-100635) were assessed on
capsaicin-induced mechanical
hypersensitivity, a
pain behavior involving
hypersensitivity of dorsal horn neurons (central sensitization). For the 5-HT(7) receptor agonists used, binding profile and intrinsic efficacy to stimulate cAMP formation in HEK-293F cells expressing the human 5-HT(7) receptor were also evaluated. AS-19 and
E-55888 were selective for 5-HT(7) receptors.
E-55888 was a full agonist whereas AS-19 and MSD-5a behaved as partial agonists, with maximal effects corresponding to 77% and 61%, respectively, of the cAMP response evoked by the full
agonist 5-HT. Our in vivo results revealed that systemic administration of 5-HT(7) receptor agonists exerted a clear-cut dose-dependent antinociceptive effect that was prevented by 5-HT(7) receptor antagonists, but not by the
5-HT(1A) receptor antagonist. The order of efficacy (E-55888>AS-19>MSD-5a) matched their in vitro efficacy as 5-HT(7) receptor agonists. Contrary to agonists, a dose-dependent promotion of mechanical
hypersensitivity was observed after administration of 5-HT(7) receptor antagonists, substantiating the involvement of the 5-HT(7) receptor in the control of
capsaicin-induced mechanical
hypersensitivity. These findings suggest that
serotonin exerts an inhibitory role in the control of nociception through activation of 5-HT(7) receptors, and point to a new potential
therapeutic use of 5-HT(7) receptor agonists in the field of
analgesia.